Abstract
To describe drug survival, disease activity and clinical response in patients with rheumatoid arthritis (RA) treated with abatacept or tocilizumab in routine care, based on prospectively registered observational data from the nationwide Danish DANBIO registry.
Original language | English |
---|---|
Journal | Annals of the Rheumatic Diseases |
Volume | 70 |
Issue number | 7 |
Pages (from-to) | 1216-22 |
Number of pages | 7 |
ISSN | 0003-4967 |
DOIs | |
Publication status | Published - 2011 |
Keywords
- Adult
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal
- Antibodies, Monoclonal, Humanized
- Antirheumatic Agents
- Arthritis, Rheumatoid
- C-Reactive Protein
- Epidemiologic Methods
- Female
- Humans
- Immunoconjugates
- Male
- Medication Adherence
- Middle Aged
- Treatment Outcome
- Tumor Necrosis Factor-alpha
- Young Adult